- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 594-608 of
936 results
2032 Exhibit: DrugsFDA FDA Approved Drug Products, httpwwwaccessdatafdagov...
Document
IPR2016-01132, No. 2032-37 Exhibit - DrugsFDA FDA Approved Drug Products, httpwwwaccessdatafdagovscriptscderdafindexcfmeventoverviewprocessApplNo021023 (P.T.A.B. Mar. 20, 2017...
|
|
Cite Document
2085 Exhibit: Assignment
Document
IPR2016-01132, No. 2085-202 Exhibit - Assignment (P.T.A.B. Sep. 8, 2017)
|
|
Cite Document
2083 Exhibit: REPLACEMENT Deposition transcript of Daniel A Bloch, PhD with Err...
Document
IPR2016-01132, No. 2083-200 Exhibit - REPLACEMENT Deposition transcript of Daniel A Bloch, PhD with Errata (P.T.A.B. Aug. 16, 2017)
|
|
Cite Document
1074 Exhibit: Exhibit 1074 Abelson et al A Stepwise Approach
Document
IPR2016-01132, No. 1074-123 Exhibit - Exhibit 1074 Abelson et al A Stepwise Approach (P.T.A.B. Jun. 30, 2017)
|
|
Cite Document
2033 Exhibit: DrugsFDA FDA Approved Drug Products, Restasis Approved, httpww...
Document
IPR2016-01132, No. 2033-38 Exhibit - DrugsFDA FDA Approved Drug Products, Restasis Approved, httpwwwaccessdatafdagovdrugsatfda docsnda200321 023 Restasis ApprovPDF (P.T.A.B. M...
|
|
Cite Document
2060 Exhibit: Allergan Inc AGN Q4 2002 Financial Release Conference Call Wedne...
Document
IPR2016-01132, No. 2060-53 Exhibit - Allergan Inc AGN Q4 2002 Financial Release Conference Call Wednesday, January 29, 2003 1100 am Fair Disclosure Financial Network (P.T.A.B. Mar. 20...
|
|
Cite Document
2098 Exhibit: Order, Allergan, Inc v Teva Pharmas USA, Inc et al, No 215 cv 1455 E...
Document
IPR2016-01132, No. 2098-221 Exhibit - Order, Allergan, Inc v Teva Pharmas USA, Inc et al, No 215 cv 1455 ED Tex, Docket No 478 September 8, 2017 (P.T.A.B. Sep. 22, 2017)
|
|
Cite Document
1042 Exhibit: Exhibit 1042 Calman CV
Document
IPR2016-01132, No. 1042-183 Exhibit - Exhibit 1042 Calman CV (P.T.A.B. Jun. 30, 2017)
|
|
Cite Document
1117 Exhibit: Exhibit 1117 Restasis TermsAndConditions5
Document
IPR2016-01132, No. 1117-166 Exhibit - Exhibit 1117 Restasis TermsAndConditions5 (P.T.A.B. Jun. 30, 2017)
|
|
Cite Document
1109 Exhibit: Exhibit 1109 Weintraub Allergan Smoothing the Wrinkles
Document
IPR2016-01132, No. 1109-158 Exhibit - Exhibit 1109 Weintraub Allergan Smoothing the Wrinkles (P.T.A.B. Jun. 30, 2017)
|
|
Cite Document
2017 Exhibit: Schaefer et al, Skin Permeability, Springer Verlag 1982
Document
IPR2016-01132, No. 2017-22 Exhibit - Schaefer et al, Skin Permeability, Springer Verlag 1982 (P.T.A.B. Mar. 20, 2017)
|
|
Cite Document
2047 Exhibit: Allergan Inc, Credit Suisse First Boston Equity Research Report, Jan...
Document
IPR2016-01132, No. 2047-47 Exhibit - Allergan Inc, Credit Suisse First Boston Equity Research Report, Jan 30, 2003 (P.T.A.B. Mar. 20, 2017)
|
|
Cite Document
2053 Exhibit: Allergan Inc, JP Morgan Equity Research Report, Nov 1, 2005
Document
IPR2016-01132, No. 2053-52 Exhibit - Allergan Inc, JP Morgan Equity Research Report, Nov 1, 2005 (P.T.A.B. Mar. 20, 2017)
|
|
Cite Document
2001 Exhibit: NDA 21 023 Cyclosporine Ophthalmic Emulsion 005 Part 1
Document
IPR2016-01132, No. 2001-6 Exhibit - NDA 21 023 Cyclosporine Ophthalmic Emulsion 005 Part 1 (P.T.A.B. Sep. 9, 2016)
|
|
Cite Document
1063 Exhibit: Exhibit 1063 Allergan Inc 2015 10 K
Document
IPR2016-01132, No. 1063-112 Exhibit - Exhibit 1063 Allergan Inc 2015 10 K (P.T.A.B. Jun. 30, 2017)
|
|
Cite Document
